Quanterix is a company that is developing digital immunoassay platform life sciences research and diagnostics.
Quanterix is a company that has developed a platform that performs single molecule analysis. The company was founded by David R. Walt in 2007, in Billerica, Massachusetts, United States.
The company offers their solution, Simoa, to provide single-molecule analysis to clinical diagnostics, drug development, and life science research. Quanterix is interested in deploying their technologies for fields such as oncology, neurology, cardiology, inflammatory, infectious diseases.